Evidence map›Paper›PMID 30423941›Full record

ArticlePharmaceutics2018

Experimental and Modeling Study of Drug Release from HPMC-Based Erodible Oral Thin Films.

Alessandra Adrover, Gabriele Varani, Patrizia Paolicelli, Stefania Petralito, Laura Di Muzio, Maria Antonietta Casadei, Ingunn Tho

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A pH-Controlled Solid Inhibitor Based onMolecules (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. 3D Printing of Drug Nanocrystals for Film Formulations.Molecules (Basel, Switzerland) · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alessandra AdroverDipartimento di Ingegneria Chimica, Materiali e Ambiente, Sapienza Universitá di Roma, Via Eudossiana 18, 00184 Rome, Italy. alessandra.adrover@uniroma1.it.ORCID 0000-0001-5939-740X
Gabriele VaraniDipartimento di Ingegneria Chimica, Materiali e Ambiente, Sapienza Universitá di Roma, Via Eudossiana 18, 00184 Rome, Italy. gabriele.varani@uniroma1.it.
Patrizia PaolicelliDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universitá di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy. patrizia.paolicelli@uniroma1.it.ORCID 0000-0003-3941-2355
Stefania PetralitoDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universitá di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy. stefania.petralito@uniroma1.it.
Laura Di MuzioDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universitá di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy. laura.dimuzio@uniroma1.it.
Maria Antonietta CasadeiDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Universitá di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy. mariaantonietta.casadei@uniroma1.it.
Ingunn ThoSection of Pharmaceutics and Social Pharmacy, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway. ingunn.tho@farmasi.uio.no.ORCID 0000-0003-4241-4183
Sapienza University of Rome · ITUniversity of Oslo · NO

Funding

Sapienza Università di Roma RM11715C536C02B1Studio sperimentale e modellistico/computazionale di celle di diffusione per studi di permeazione di formulazioni ad uso topico RM11715C536C02B1
6 · The paper itself

Abstract

In this work hydroxypropyl methylcellulose (HPMC) fast-dissolving thin films for oral administration are investigated. Furosemide (Class IV of the Biopharmaceutical Classification System) has been used as a model drug for in vitro release tests using three different set-ups: the Franz cell, the millifluidic flow-through device, and the paddle type dissolution apparatus (USP II). In order to enable drug incorporation within HPMC films, a multifunctional excipient, hydroxypropyl- β -cyclodextrin (HP- β -CD) has been included in the formulation, and the influence of HP- β -CD on film swelling, erosion, and release properties has been investigated. Mathematical models capable of describing the swelling and release processes from HPMC erodible thin films in different apparatuses have been developed. In particular, we propose a new model for the description of drug transport and release in a Franz cell that accounts for the effect of the unavoidable imperfect mixing of the receptor chamber.

Indexed as

cyclodextrinserodible thin filmserosionFranz cellfurosemideHPMCmillifluidic flow-through deviceUSP II

Identifiers

PMID30423941
PMCPMC6320981
OpenAlexW2900136654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.